Vault-13

Birchview Capital, LP

BURLINGTON, VT · CIK 1618205 · 13F filing filed 2025-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$100.7m reported value -12.6% vs Q1 2025
71positions
56.8%in top 10
12 new 15 added 13 reduced 9 sold out vs Q1 2025

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BRISTOL-MYERS SQUIBB CO COM BMY BMY 323,358 $15.0m14.86% 14.86% ReducedShares held: Q3 2024 1.4m, Q4 2024 1.4m, Q1 2025 685.2k, Q2 2025 323.4k -361.8k -361,834 -52.8%
2 KLA CORP COM NEW KLAC KLAC 15,848 $14.2m14.10% 14.10% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 15.8k
3 CORCEPT THERAPEUTICS INC COM CORT CORT 67,200 $4.9m4.90% 4.90% AddedShares held: Q3 2024 148.0k, Q4 2024 148.0k, Q1 2025 66.0k, Q2 2025 67.2k +1.2k +1,200 1.8%
4 OVINTIV INC COM OVV OVV 107,500 $4.1m4.06% 4.06% AddedShares held: Q3 2024 104.4k, Q4 2024 104.4k, Q1 2025 52.2k, Q2 2025 107.5k +55.3k +55,300 105.9%
5 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 187,800 $4.1m4.02% 4.02% ReducedShares held: Q3 2024 800.8k, Q4 2024 676.8k, Q1 2025 263.4k, Q2 2025 187.8k -75.6k -75,600 -28.7%
6 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 30,940 $3.9m3.86% 3.86% AddedShares held: Q3 2024 60.5k, Q4 2024 60.5k, Q1 2025 30.2k, Q2 2025 30.9k +700 +700 2.3%
7 PHREESIA INC COM PHR PHR 114,700 $3.3m3.24% 3.24% UnchangedShares held: Q3 2024 229.4k, Q4 2024 229.4k, Q1 2025 114.7k, Q2 2025 114.7k
8 PROTHENA CORP PLC SHS PRTA PRTA 451,019 $2.7m2.72% 2.72% AddedShares held: Q3 2024 419.1k, Q4 2024 609.1k, Q1 2025 333.0k, Q2 2025 451.0k +118.0k +118,045 35.5%
9 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 48,000 $2.7m2.63% 2.63% ReducedShares held: Q3 2024 96.0k, Q4 2024 96.0k, Q1 2025 48.0k, Q2 2025 48.0k -2 -2 0.0%
10 STOKE THERAPEUTICS INC COM STOK STOK 210,000 $2.4m2.37% 2.37% ReducedShares held: Q3 2024 420.0k, Q4 2024 420.0k, Q1 2025 210.0k, Q2 2025 210.0k -5 -5 0.0%
11 ELUTIA INC CL A COM ELUT ELUT 1,159,059 $2.3m2.28% 2.28% ReducedShares held: Q3 2024 2.6m, Q4 2024 2.5m, Q1 2025 1.2m, Q2 2025 1.2m -28.7k -28,676 -2.4%
12 CASTLE BIOSCIENCES INC COM CSTL CSTL 110,600 $2.3m2.24% 2.24% AddedShares held: Q3 2024 116.0k, Q4 2024 156.0k, Q1 2025 88.4k, Q2 2025 110.6k +22.2k +22,196 25.1%
13 QUIDEL CORP COM QDEL QDEL 72,548 $2.1m2.08% 2.08% AddedShares held: Q3 2024 135.2k, Q4 2024 135.2k, Q1 2025 67.6k, Q2 2025 72.5k +4.9k +4,929 7.3%
14 EQT CORP COM EQT EQT 34,619 $2.0m2.01% 2.01% UnchangedShares held: Q3 2024 69.2k, Q4 2024 69.2k, Q1 2025 34.6k, Q2 2025 34.6k
15 HARROW INC COM HROW HROW 60,000 $1.8m1.82% 1.82% ReducedShares held: Q3 2024 145.8k, Q4 2024 145.8k, Q1 2025 72.9k, Q2 2025 60.0k -12.9k -12,910 -17.7%
16 NOVOCURE LTD ORD SHS NVCR NVCR 101,000 $1.8m1.79% 1.79% AddedShares held: Q3 2024 40.0k, Q4 2024 62.0k, Q1 2025 31.0k, Q2 2025 101.0k +70.0k +70,000 225.8%
17 AXOGEN INC COM AXGN AXGN 161,000 $1.7m1.73% 1.73% UnchangedShares held: Q3 2024 394.0k, Q4 2024 394.0k, Q1 2025 161.0k, Q2 2025 161.0k
18 BIODESIX INC COM COM 5,736,113 $1.6m1.61% 1.61% UnchangedShares held: Q3 2024 11.2m, Q4 2024 11.3m, Q1 2025 5.7m, Q2 2025 5.7m
19 TRAVERE THERAPEUTICS INC COM TVTX TVTX 103,000 $1.5m1.51% 1.51% ReducedShares held: Q3 2024 296.0k, Q4 2024 296.0k, Q1 2025 138.0k, Q2 2025 103.0k -35.0k -35,000 -25.4%
20 FOGHORN THERAPEUTICS INC COM FHTX FHTX 310,930 $1.5m1.45% 1.45% UnchangedShares held: Q3 2024 641.9k, Q4 2024 621.9k, Q1 2025 310.9k, Q2 2025 310.9k
21 ALKERMES PLC SHS ALKS ALKS 50,000 $1.4m1.42% 1.42% UnchangedShares held: Q3 2024 100.0k, Q4 2024 100.0k, Q1 2025 50.0k, Q2 2025 50.0k
22 MASIMO CORP COM MASI MASI 8,280 $1.4m1.38% 1.38% ReducedShares held: Q3 2024 30.6k, Q4 2024 30.6k, Q1 2025 11.3k, Q2 2025 8.3k -3.0k -3,000 -26.6%
23 UNIQURE NV SHS QURE QURE 98,697 $1.4m1.37% 1.37% AddedShares held: Q3 2024 40.0k, Q4 2024 40.0k, Q1 2025 88.7k, Q2 2025 98.7k +10.0k +10,000 11.3%
24 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 4,250 $1.2m1.21% 1.21% ReducedShares held: Q3 2024 20.0k, Q4 2024 20.0k, Q1 2025 7.5k, Q2 2025 4.2k -3.2k -3,250 -43.3%
25 DOCGO INC COM DCGO DCGO 764,062 $1.2m1.19% 1.19% ReducedShares held: Q3 2024 1.0m, Q4 2024 1.5m, Q1 2025 864.1k, Q2 2025 764.1k -100.0k -100,000 -11.6%
26 TREACE MED CONCEPTS INC COM TMCI TMCI 176,947 $1.0m1.03% 1.03% AddedShares held: Q3 2024 136.7k, Q4 2024 322.7k, Q1 2025 164.9k, Q2 2025 176.9k +12.0k +12,000 7.3%
27 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 178,768 $870.6k0.86% 0.86% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 128.8k, Q2 2025 178.8k +50.0k +50,000 38.8%
28 KINIKSA PHARMACEUTICALS LTD COM CL A COM CL A 30,000 $830.1k0.82% 0.82% ReducedShares held: Q3 2024 60.0k, Q4 2024 60.0k, Q1 2025 30.0k, Q2 2025 30.0k -6 -6 -0.0%
29 FREEPORT-MCMORAN INC CL B FCX FCX 18,033 $781.7k0.78% 0.78% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 18.0k
30 KALVISTA PHARMACEUTICALS INC COM KALV KALV 67,000 $757.4k0.75% 0.75% ReducedShares held: Q3 2024 164.0k, Q4 2024 134.0k, Q1 2025 67.0k, Q2 2025 67.0k -2 -2 0.0%
31 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 36,000 $746.6k0.74% 0.74% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 36.0k
32 APOGEE THERAPEUTICS INC COM COM 16,000 $694.9k0.69% 0.69% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 8.0k, Q2 2025 16.0k +8.0k +8,000 100.0%
33 OUTSET MED INC COM OM OM 34,584 $664.4k0.66% 0.66% AddedShares held: Q3 2024 20.0k, Q4 2024 737.5k, Q1 2025 24.6k, Q2 2025 34.6k +10.0k +10,000 40.7%
34 XENON PHARMACEUTICALS INC COM XENE XENE 21,000 $657.3k0.65% 0.65% UnchangedShares held: Q3 2024 20.0k, Q4 2024 20.0k, Q1 2025 21.0k, Q2 2025 21.0k
35 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 18,000 $654.5k0.65% 0.65% AddedShares held: Q3 2024 0, Q4 2024 32.0k, Q1 2025 16.0k, Q2 2025 18.0k +2.0k +2,000 12.5%
36 AXSOME THERAPEUTICS INC COM AXSM AXSM 6,000 $626.3k0.62% 0.62% UnchangedShares held: Q3 2024 8.0k, Q4 2024 8.0k, Q1 2025 6.0k, Q2 2025 6.0k
37 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 134,000 $570.8k0.57% 0.57% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 134.0k
38 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 16,000 $566.7k0.56% 0.56% UnchangedShares held: Q3 2024 0, Q4 2024 16.0k, Q1 2025 16.0k, Q2 2025 16.0k
39 INTELLIA THERAPEUTICS INC COM NTLA NTLA 60,000 $562.8k0.56% 0.56% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 60.0k
40 ORTHOPEDIATRICS CORP COM KIDS KIDS 26,000 $558.5k0.55% 0.55% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 20.0k, Q2 2025 26.0k +6.0k +6,000 30.0%
41 IMMUNOME INC COM IMNM IMNM 60,000 $558.0k0.55% 0.55% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 60.0k
42 XENCOR INC COM XNCR XNCR 70,000 $550.2k0.55% 0.55% AddedShares held: Q3 2024 24.6k, Q4 2024 52.0k, Q1 2025 26.0k, Q2 2025 70.0k +44.0k +44,000 169.2%
43 HALOZYME THERAPEUTICS INC COM HALO HALO 10,000 $520.2k0.52% 0.52% UnchangedShares held: Q3 2024 20.0k, Q4 2024 20.0k, Q1 2025 10.0k, Q2 2025 10.0k
44 PACIFIC BIOSCIENCES CALIF IN COM PACB PACB 400,000 $496.0k0.49% 0.49% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 400.0k
45 INHIBRX BIOSCIENCES INC COM INBX INBX 32,110 $458.2k0.46% 0.46% UnchangedShares held: Q3 2024 64.2k, Q4 2024 64.2k, Q1 2025 32.1k, Q2 2025 32.1k
46 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 8,000 $377.6k0.37% 0.37% UnchangedShares held: Q3 2024 0, Q4 2024 8.0k, Q1 2025 8.0k, Q2 2025 8.0k
47 ALPHATEC HLDGS INC COM NEW ATEC ATEC 33,000 $366.3k0.36% 0.36% UnchangedShares held: Q3 2024 396.0k, Q4 2024 116.0k, Q1 2025 33.0k, Q2 2025 33.0k
48 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 40,000 $358.4k0.36% 0.36% UnchangedShares held: Q3 2024 80.0k, Q4 2024 80.0k, Q1 2025 40.0k, Q2 2025 40.0k
49 BLUEPRINT MEDICINES CORP COM BPMC BPMC 2,700 $346.1k0.34% 0.34% UnchangedShares held: Q3 2024 5.4k, Q4 2024 5.4k, Q1 2025 2.7k, Q2 2025 2.7k
50 CYTOKINETICS INC COM NEW CYTK CYTK 10,000 $330.4k0.33% 0.33% UnchangedShares held: Q3 2024 20.0k, Q4 2024 20.0k, Q1 2025 10.0k, Q2 2025 10.0k
51 CANDEL THERAPEUTICS INC COM CADL CADL 60,000 $303.6k0.30% 0.30% UnchangedShares held: Q3 2024 0, Q4 2024 120.0k, Q1 2025 60.0k, Q2 2025 60.0k
52 TELA BIO INC COM TELA TELA 155,000 $300.7k0.30% 0.30% UnchangedShares held: Q3 2024 0, Q4 2024 250.0k, Q1 2025 155.0k, Q2 2025 155.0k
53 COGENT BIOSCIENCES INC COM COGT COGT 40,000 $287.2k0.29% 0.29% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 40.0k
54 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 40,300 $261.9k0.26% 0.26% UnchangedShares held: Q3 2024 80.0k, Q4 2024 80.0k, Q1 2025 40.3k, Q2 2025 40.3k
55 10X GENOMICS INC CL A COM TXG TXG 22,000 $254.8k0.25% 0.25% ReducedShares held: Q3 2024 60.0k, Q4 2024 100.0k, Q1 2025 50.0k, Q2 2025 22.0k -28.0k -28,000 -56.0%
56 APELLIS PHARMACEUTICALS INC COM APLS APLS 14,000 $242.3k0.24% 0.24% UnchangedShares held: Q3 2024 28.0k, Q4 2024 28.0k, Q1 2025 14.0k, Q2 2025 14.0k
57 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 25,000 $239.8k0.24% 0.24% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 25.0k
58 BRIDGEBIO PHARMA INC COM BBIO BBIO 5,000 $215.9k0.21% 0.21% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 5.0k
59 NEUROPACE INC COM NPCE NPCE 16,442 $183.2k0.18% 0.18% UnchangedShares held: Q3 2024 0, Q4 2024 20.0k, Q1 2025 16.4k, Q2 2025 16.4k
60 GOSSAMER BIO INC COM GOSS GOSS 138,176 $170.0k0.17% 0.17% UnchangedShares held: Q3 2024 276.4k, Q4 2024 276.4k, Q1 2025 138.2k, Q2 2025 138.2k
61 AMICUS THERAPEUTICS INC COM FOLD FOLD 28,000 $160.4k0.16% 0.16% UnchangedShares held: Q3 2024 56.0k, Q4 2024 56.0k, Q1 2025 28.0k, Q2 2025 28.0k
62 ZENAS BIOPHARMA INC COM ZBIO ZBIO 16,500 $159.9k0.16% 0.16% UnchangedShares held: Q3 2024 0, Q4 2024 33.0k, Q1 2025 16.5k, Q2 2025 16.5k
63 CULLINAN THERAPEUTICS INC COM CGEM CGEM 20,000 $150.6k0.15% 0.15% UnchangedShares held: Q3 2024 40.0k, Q4 2024 40.0k, Q1 2025 20.0k, Q2 2025 20.0k
64 KARYOPHARM THERAPEUTICS INC COM COM 27,985 $120.6k0.12% 0.12% UnchangedShares held: Q3 2024 939.7k, Q4 2024 839.7k, Q1 2025 28.0k, Q2 2025 28.0k
65 APPLIED THERAPEUTICS INC COM APLT APLT 280,000 $87.1k0.09% 0.09% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 280.0k
66 VENTYX BIOSCIENCES INC COM VTYX VTYX 28,800 $61.6k0.06% 0.06% UnchangedShares held: Q3 2024 57.6k, Q4 2024 57.6k, Q1 2025 28.8k, Q2 2025 28.8k
67 INFLARX NV COM IFRX IFRX 50,000 $39.5k0.04% 0.04% UnchangedShares held: Q3 2024 100.0k, Q4 2024 100.0k, Q1 2025 50.0k, Q2 2025 50.0k
68 APTEVO THERAPEUTICS INC COM NEW COM NEW 10,000 $30.5k0.03% 0.03% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 10.0k
69 ALUMIS INC COM ALMS ALMS 10,000 $30.0k0.03% 0.03% UnchangedShares held: Q3 2024 20.0k, Q4 2024 20.0k, Q1 2025 10.0k, Q2 2025 10.0k
70 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 17,000 $19.7k0.02% 0.02% UnchangedShares held: Q3 2024 32.0k, Q4 2024 34.0k, Q1 2025 17.0k, Q2 2025 17.0k
71 ACCELERATE DIAGNOSTICS INC COM COM 325,239 $2.1k0.00% 0.00% UnchangedShares held: Q3 2024 650.5k, Q4 2024 650.5k, Q1 2025 325.2k, Q2 2025 325.2k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
SPRINGWORKS THERAPEUTICS INC SWTX SWTX 8,280 $365.4k8.3k shares
PULMONX CORP LUNG LUNG 51,000 $343.2k51.0k shares
ARVINAS INC ARVN ARVN 30,000 $210.6k30.0k shares
KEROS THERAPEUTICS INC KROS KROS 15,000 $152.8k15.0k shares
LIQUIDIA CORPORATION LQDA LQDA 10,013 $147.7k10.0k shares
DIREXION SHS ETF TR TECL TECL 20,000 $144.4k20.0k shares
ATARA BIOTHERAPEUTICS INC ATRA ATRA 22,000 $130.7k22.0k shares
2SEVENTY BIO INC TSVT TSVT 15,500 $76.6k15.5k shares
COMPASS THERAPEUTICS INC CMPX CMPX 24,000 $45.6k24.0k shares